A?medication?(also referred to as?medicine,?pharmaceutical drug, or simply?drug) is a?drug?used to?diagnose,?cure,?treat, or?prevent?disease.?Drug therapy (pharmacotherapy) is an important part of the?medical field?and relies on the science of?pharmacology?for continual advancement and on?pharmacy?for appropriate management.
This report aims to provide a comprehensive presentation of the global market for Non-prescription Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-prescription Drugs. This report contains market size and forecasts of Non-prescription Drugs in global, including the following market information:
Global Non-prescription Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Non-prescription Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Non-prescription Drugs companies in 2022 (%)
The global Non-prescription Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Brand Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-prescription Drugs include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non-prescription Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-prescription Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-prescription Drugs Market Segment Percentages, by Type, 2022 (%)
Brand Drugs
Generic Drug
Global Non-prescription Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-prescription Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Non-prescription Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-prescription Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-prescription Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Non-prescription Drugs revenues share in global market, 2022 (%)
Key companies Non-prescription Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Non-prescription Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-prescription Drugs, market overview.
Chapter 2: Global Non-prescription Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Non-prescription Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-prescription Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-prescription Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non-prescription Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-prescription Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-prescription Drugs Overall Market Size
2.1 Global Non-prescription Drugs Market Size: 2022 VS 2029
2.2 Global Non-prescription Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Non-prescription Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Non-prescription Drugs Players in Global Market
3.2 Top Global Non-prescription Drugs Companies Ranked by Revenue
3.3 Global Non-prescription Drugs Revenue by Companies
3.4 Global Non-prescription Drugs Sales by Companies
3.5 Global Non-prescription Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Non-prescription Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Non-prescription Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-prescription Drugs Players in Global Market
3.8.1 List of Global Tier 1 Non-prescription Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-prescription Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-prescription Drugs Market Size Markets, 2022 & 2029
4.1.2 Brand Drugs
4.1.3 Generic Drug
4.2 By Type - Global Non-prescription Drugs Revenue & Forecasts
4.2.1 By Type - Global Non-prescription Drugs Revenue, 2018-2023
4.2.2 By Type - Global Non-prescription Drugs Revenue, 2024-2029
4.2.3 By Type - Global Non-prescription Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Non-prescription Drugs Sales & Forecasts
4.3.1 By Type - Global Non-prescription Drugs Sales, 2018-2023
4.3.2 By Type - Global Non-prescription Drugs Sales, 2024-2029
4.3.3 By Type - Global Non-prescription Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Non-prescription Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-prescription Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Non-prescription Drugs Revenue & Forecasts
5.2.1 By Application - Global Non-prescription Drugs Revenue, 2018-2023
5.2.2 By Application - Global Non-prescription Drugs Revenue, 2024-2029
5.2.3 By Application - Global Non-prescription Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Non-prescription Drugs Sales & Forecasts
5.3.1 By Application - Global Non-prescription Drugs Sales, 2018-2023
5.3.2 By Application - Global Non-prescription Drugs Sales, 2024-2029
5.3.3 By Application - Global Non-prescription Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Non-prescription Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Non-prescription Drugs Market Size, 2022 & 2029
6.2 By Region - Global Non-prescription Drugs Revenue & Forecasts
6.2.1 By Region - Global Non-prescription Drugs Revenue, 2018-2023
6.2.2 By Region - Global Non-prescription Drugs Revenue, 2024-2029
6.2.3 By Region - Global Non-prescription Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Non-prescription Drugs Sales & Forecasts
6.3.1 By Region - Global Non-prescription Drugs Sales, 2018-2023
6.3.2 By Region - Global Non-prescription Drugs Sales, 2024-2029
6.3.3 By Region - Global Non-prescription Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Non-prescription Drugs Revenue, 2018-2029
6.4.2 By Country - North America Non-prescription Drugs Sales, 2018-2029
6.4.3 US Non-prescription Drugs Market Size, 2018-2029
6.4.4 Canada Non-prescription Drugs Market Size, 2018-2029
6.4.5 Mexico Non-prescription Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Non-prescription Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Non-prescription Drugs Sales, 2018-2029
6.5.3 Germany Non-prescription Drugs Market Size, 2018-2029
6.5.4 France Non-prescription Drugs Market Size, 2018-2029
6.5.5 U.K. Non-prescription Drugs Market Size, 2018-2029
6.5.6 Italy Non-prescription Drugs Market Size, 2018-2029
6.5.7 Russia Non-prescription Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Non-prescription Drugs Market Size, 2018-2029
6.5.9 Benelux Non-prescription Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Non-prescription Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Non-prescription Drugs Sales, 2018-2029
6.6.3 China Non-prescription Drugs Market Size, 2018-2029
6.6.4 Japan Non-prescription Drugs Market Size, 2018-2029
6.6.5 South Korea Non-prescription Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Non-prescription Drugs Market Size, 2018-2029
6.6.7 India Non-prescription Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Non-prescription Drugs Revenue, 2018-2029
6.7.2 By Country - South America Non-prescription Drugs Sales, 2018-2029
6.7.3 Brazil Non-prescription Drugs Market Size, 2018-2029
6.7.4 Argentina Non-prescription Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-prescription Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Non-prescription Drugs Sales, 2018-2029
6.8.3 Turkey Non-prescription Drugs Market Size, 2018-2029
6.8.4 Israel Non-prescription Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Non-prescription Drugs Market Size, 2018-2029
6.8.6 UAE Non-prescription Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Non-prescription Drugs Major Product Offerings
7.1.4 Pfizer Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Non-prescription Drugs Major Product Offerings
7.2.4 Roche Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Non-prescription Drugs Major Product Offerings
7.3.4 Sanofi Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Non-prescription Drugs Major Product Offerings
7.4.4 Johnson & Johnson Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Merck & Co. (MSD)
7.5.1 Merck & Co. (MSD) Company Summary
7.5.2 Merck & Co. (MSD) Business Overview
7.5.3 Merck & Co. (MSD) Non-prescription Drugs Major Product Offerings
7.5.4 Merck & Co. (MSD) Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck & Co. (MSD) Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Non-prescription Drugs Major Product Offerings
7.6.4 Novartis Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 AbbVie
7.7.1 AbbVie Company Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Non-prescription Drugs Major Product Offerings
7.7.4 AbbVie Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.7.5 AbbVie Key News & Latest Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Company Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Non-prescription Drugs Major Product Offerings
7.8.4 Gilead Sciences Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Gilead Sciences Key News & Latest Developments
7.9 GlaxoSmithKline (GSK)
7.9.1 GlaxoSmithKline (GSK) Company Summary
7.9.2 GlaxoSmithKline (GSK) Business Overview
7.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Major Product Offerings
7.9.4 GlaxoSmithKline (GSK) Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.9.5 GlaxoSmithKline (GSK) Key News & Latest Developments
7.10 Amgen
7.10.1 Amgen Company Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Non-prescription Drugs Major Product Offerings
7.10.4 Amgen Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Amgen Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca Non-prescription Drugs Business Overview
7.11.3 AstraZeneca Non-prescription Drugs Major Product Offerings
7.11.4 AstraZeneca Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.11.5 AstraZeneca Key News & Latest Developments
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Company Summary
7.12.2 Bristol-Myers Squibb Non-prescription Drugs Business Overview
7.12.3 Bristol-Myers Squibb Non-prescription Drugs Major Product Offerings
7.12.4 Bristol-Myers Squibb Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Bristol-Myers Squibb Key News & Latest Developments
7.13 Eli Lilly
7.13.1 Eli Lilly Company Summary
7.13.2 Eli Lilly Non-prescription Drugs Business Overview
7.13.3 Eli Lilly Non-prescription Drugs Major Product Offerings
7.13.4 Eli Lilly Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Eli Lilly Key News & Latest Developments
7.14 Teva
7.14.1 Teva Company Summary
7.14.2 Teva Business Overview
7.14.3 Teva Non-prescription Drugs Major Product Offerings
7.14.4 Teva Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Teva Key News & Latest Developments
7.15 Bayer
7.15.1 Bayer Company Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Non-prescription Drugs Major Product Offerings
7.15.4 Bayer Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Bayer Key News & Latest Developments
7.16 Novo Nordisk
7.16.1 Novo Nordisk Company Summary
7.16.2 Novo Nordisk Business Overview
7.16.3 Novo Nordisk Non-prescription Drugs Major Product Offerings
7.16.4 Novo Nordisk Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Novo Nordisk Key News & Latest Developments
7.17 Allergan
7.17.1 Allergan Company Summary
7.17.2 Allergan Business Overview
7.17.3 Allergan Non-prescription Drugs Major Product Offerings
7.17.4 Allergan Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Allergan Key News & Latest Developments
7.18 Takeda
7.18.1 Takeda Company Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Non-prescription Drugs Major Product Offerings
7.18.4 Takeda Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Takeda Key News & Latest Developments
7.19 Boehringer Ingelheim
7.19.1 Boehringer Ingelheim Company Summary
7.19.2 Boehringer Ingelheim Business Overview
7.19.3 Boehringer Ingelheim Non-prescription Drugs Major Product Offerings
7.19.4 Boehringer Ingelheim Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Boehringer Ingelheim Key News & Latest Developments
7.20 Takeda
7.20.1 Takeda Company Summary
7.20.2 Takeda Business Overview
7.20.3 Takeda Non-prescription Drugs Major Product Offerings
7.20.4 Takeda Non-prescription Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Takeda Key News & Latest Developments
8 Global Non-prescription Drugs Production Capacity, Analysis
8.1 Global Non-prescription Drugs Production Capacity, 2018-2029
8.2 Non-prescription Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-prescription Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-prescription Drugs Supply Chain Analysis
10.1 Non-prescription Drugs Industry Value Chain
10.2 Non-prescription Drugs Upstream Market
10.3 Non-prescription Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-prescription Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Non-prescription Drugs in Global Market
Table 2. Top Non-prescription Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Non-prescription Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Non-prescription Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Non-prescription Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Non-prescription Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Non-prescription Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Non-prescription Drugs Product Type
Table 9. List of Global Tier 1 Non-prescription Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-prescription Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Non-prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Non-prescription Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Non-prescription Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Non-prescription Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Non-prescription Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Non-prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Non-prescription Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Non-prescription Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Non-prescription Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Non-prescription Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Non-prescription Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Non-prescription Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Non-prescription Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Non-prescription Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Non-prescription Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Non-prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Non-prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Non-prescription Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Non-prescription Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Non-prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Non-prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Non-prescription Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Non-prescription Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Non-prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Non-prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Non-prescription Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Non-prescription Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Non-prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Non-prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Non-prescription Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Non-prescription Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Non-prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Non-prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Non-prescription Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Non-prescription Drugs Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Non-prescription Drugs Product Offerings
Table 48. Pfizer Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Non-prescription Drugs Product Offerings
Table 52. Roche Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Non-prescription Drugs Product Offerings
Table 56. Sanofi Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Non-prescription Drugs Product Offerings
Table 60. Johnson & Johnson Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Merck & Co. (MSD) Company Summary
Table 63. Merck & Co. (MSD) Non-prescription Drugs Product Offerings
Table 64. Merck & Co. (MSD) Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Merck & Co. (MSD) Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Non-prescription Drugs Product Offerings
Table 68. Novartis Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. AbbVie Company Summary
Table 71. AbbVie Non-prescription Drugs Product Offerings
Table 72. AbbVie Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. AbbVie Key News & Latest Developments
Table 74. Gilead Sciences Company Summary
Table 75. Gilead Sciences Non-prescription Drugs Product Offerings
Table 76. Gilead Sciences Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Gilead Sciences Key News & Latest Developments
Table 78. GlaxoSmithKline (GSK) Company Summary
Table 79. GlaxoSmithKline (GSK) Non-prescription Drugs Product Offerings
Table 80. GlaxoSmithKline (GSK) Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. GlaxoSmithKline (GSK) Key News & Latest Developments
Table 82. Amgen Company Summary
Table 83. Amgen Non-prescription Drugs Product Offerings
Table 84. Amgen Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Amgen Key News & Latest Developments
Table 86. AstraZeneca Company Summary
Table 87. AstraZeneca Non-prescription Drugs Product Offerings
Table 88. AstraZeneca Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. AstraZeneca Key News & Latest Developments
Table 90. Bristol-Myers Squibb Company Summary
Table 91. Bristol-Myers Squibb Non-prescription Drugs Product Offerings
Table 92. Bristol-Myers Squibb Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Bristol-Myers Squibb Key News & Latest Developments
Table 94. Eli Lilly Company Summary
Table 95. Eli Lilly Non-prescription Drugs Product Offerings
Table 96. Eli Lilly Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Eli Lilly Key News & Latest Developments
Table 98. Teva Company Summary
Table 99. Teva Non-prescription Drugs Product Offerings
Table 100. Teva Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Teva Key News & Latest Developments
Table 102. Bayer Company Summary
Table 103. Bayer Non-prescription Drugs Product Offerings
Table 104. Bayer Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Bayer Key News & Latest Developments
Table 106. Novo Nordisk Company Summary
Table 107. Novo Nordisk Non-prescription Drugs Product Offerings
Table 108. Novo Nordisk Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Novo Nordisk Key News & Latest Developments
Table 110. Allergan Company Summary
Table 111. Allergan Non-prescription Drugs Product Offerings
Table 112. Allergan Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. Allergan Key News & Latest Developments
Table 114. Takeda Company Summary
Table 115. Takeda Non-prescription Drugs Product Offerings
Table 116. Takeda Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. Takeda Key News & Latest Developments
Table 118. Boehringer Ingelheim Company Summary
Table 119. Boehringer Ingelheim Non-prescription Drugs Product Offerings
Table 120. Boehringer Ingelheim Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. Boehringer Ingelheim Key News & Latest Developments
Table 122. Takeda Company Summary
Table 123. Takeda Non-prescription Drugs Product Offerings
Table 124. Takeda Non-prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 125. Takeda Key News & Latest Developments
Table 126. Non-prescription Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 127. Global Non-prescription Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global Non-prescription Drugs Production by Region, 2018-2023 (K Units)
Table 129. Global Non-prescription Drugs Production by Region, 2024-2029 (K Units)
Table 130. Non-prescription Drugs Market Opportunities & Trends in Global Market
Table 131. Non-prescription Drugs Market Drivers in Global Market
Table 132. Non-prescription Drugs Market Restraints in Global Market
Table 133. Non-prescription Drugs Raw Materials
Table 134. Non-prescription Drugs Raw Materials Suppliers in Global Market
Table 135. Typical Non-prescription Drugs Downstream
Table 136. Non-prescription Drugs Downstream Clients in Global Market
Table 137. Non-prescription Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Non-prescription Drugs Segment by Type in 2022
Figure 2. Non-prescription Drugs Segment by Application in 2022
Figure 3. Global Non-prescription Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-prescription Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Non-prescription Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Non-prescription Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Non-prescription Drugs Revenue in 2022
Figure 9. By Type - Global Non-prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Non-prescription Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Non-prescription Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Non-prescription Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Non-prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Non-prescription Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Non-prescription Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Non-prescription Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Non-prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Non-prescription Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Non-prescription Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Non-prescription Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Non-prescription Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Non-prescription Drugs Sales Market Share, 2018-2029
Figure 23. US Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Non-prescription Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Non-prescription Drugs Sales Market Share, 2018-2029
Figure 28. Germany Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Non-prescription Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Non-prescription Drugs Sales Market Share, 2018-2029
Figure 37. China Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Non-prescription Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Non-prescription Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Non-prescription Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Non-prescription Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Non-prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Non-prescription Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Non-prescription Drugs by Region, 2022 VS 2029
Figure 54. Non-prescription Drugs Industry Value Chain
Figure 55. Marketing Channels
